`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`
`
`PAR PHARMACEUTICAL, INC.,
`Petitioner,
`
`v.
`
`HORIZON THERAPEUTICS, LLC,
`Patent Owner.
`
`_____________________
`
`Case IPR2017-01769
`Patent 9,326,966
`_____________________
`
`PETITIONER’S UPDATED MANDATORY NOTICES
`
`
`
`
`
`
`
`
`
`
`
`Mail Stop “PATENT BOARD”
`Patent Trial and Appeal Board
`U.S. Patent and Trademark Office
`P.O. Box 1450
`Alexandria, VA 22313-1450
`
`
`
`
`
`IPR2017-01769 (Patent 9,326,966)
`Petitioner’s Updated Mandatory Notices
`
`Petitioner Par Pharmaceutical, Inc. (“Par”) updates its mandatory notices
`
`
`
`regarding lead counsel, back-up counsel, and service information pursuant to
`
`37 C.F.R. § 42.8(a)(3).
`
`Pursuant to 37 C.F.R. § 42.8(a)(3), Par identifies the following lead and
`
`back-up counsel for this proceeding, and their corresponding service information,
`
`adding additional back-up counsel:
`
`Lead Counsel
`David H. Silverstein (Reg. No. 61,948)
`Axinn, Veltrop & Harkrider LLP
`114 West 47th Street
`New York, NY 10036
`Tel: 212-261-5651
`Fax: 212-728-2201
`dsilverstein@axinn.com
`
`Backup Counsel
`Aziz Burgy (Reg. No. 51,514)
`Axinn, Veltrop & Harkrider LLP
`950 F Street, N.W.
`Washington, DC 20004
`Tel: (202) 912-4700
`Fax: (202) 912-4701
`aburgy@axinn.com
`Dan Feng Mei (Reg. No. 71,518)
`Axinn, Veltrop & Harkrider LLP
`114 West 47th Street, 22nd Floor
`New York, NY 10036
`Tel: 212-728-2216
`Fax: 212-728-2201
`dmei@axinn.com
`Ravicti@axinn.com
`Christopher M. Gallo (Reg. No. 70,291)
`Axinn, Veltrop & Harkrider LLP
`950 F Street N.W., 7th Floor
`Washington, DC 20004
`Tel: (202) 912-4700
`Fax: (202) 912-4701
`cgallo@axinn.com
`
`
`
`1
`
`
`
`IPR2017-01769 (Patent 9,326,966)
`Petitioner’s Updated Mandatory Notices
`
`Pursuant to 37 C.F.R. § 42.8(b)(4), please direct all correspondence
`
`
`
`regarding this proceeding to the lead counsel at the address listed above. Petitioner
`
`also consents to electronic service by email to dsilverstein@axinn.com,
`
`aburgy@axinn.com, dmei@axinn.com, cgallo@axinn.com, and
`
`Ravicti@axinn.com.
`
`The Patent Trial and Appeal Board is hereby authorized to charge any fees
`
`associated with this proceeding to Deposit Account 013050.
`
`
`Dated: August 21, 2018
`
`
`
`
`David H. Silverstein (Reg. No. 61,948)
`AXINN, VELTROP & HARKRIDER LLP
`114 West 47th Street, 22nd Floor
`New York, NY 10036
`(212) 261-5651
`
`Attorney for Petitioner
`Par Pharmaceutical, Inc.
`
`
`
`2
`
`
`
`
`
`IPR2017-01769 (Patent 9,326,966)
`Certificate of Service
`
`CERTIFICATION OF SERVICE
`The undersigned hereby certifies that the above-captioned “Petitioner’s
`
`Updated Mandatory Notices” was served in its entirety on August 21, 2018
`
`through the Patent Trial and Appeal Board End to End (PTAB E2E) system, and
`
`additionally upon the following parties via Electronic Mail, as agreed to by
`
`counsel:
`
`Robert Green: rgreen@greengriffith.com
`Matthew Phillips: mphillips@lpiplaw.com
`Emer Simic: esimic@greengriffith.com
`Dennis Bennett: dennisbennett@globalpatentgroup.com
`Ann Kotze: akotze@greengriffith.com
`
`
`
`Dated: August 21, 2018
`
`
`
`
`
`David H. Silverstein (Reg. No. 61,948)
`AXINN, VELTROP & HARKRIDER LLP
`114 West 47th Street, 22nd Floor
`New York, NY 10036
`(212) 261-5651
`
`Attorney for Petitioner
`Par Pharmaceutical, Inc.
`
`
`1
`
`
`
`
`
`